Scientific evidence

The effect of pharmacogenetics on medications in the treatment of various diseases and disorders


The clinical effectiveness and cost-effectiveness in the treatment of depression

Pharmacogenetics affects many psychotropics and especially patients with depression can benefit from pharmacogenetic testing. The Abomics pharmacogenetic interpretation report makes understanding and applying the results to clinical practice fast and easy. See a sample report.


The clinical effectiveness and cost-effectiveness in polypharmacy

Polypharmacy predisposes the patient to adverse drug reactions and drug-drug interactions and can make medication decisions challenging for the treating doctor. Pharmacogenetic testing supports medication decision-making.


Using pharmacogenetics in cardiology

Clopidogrel is used to prevent venous thromboembolisms, but its effect is insufficient for approximately 30 % of patients. With pharmacogenetic testing you can predict the patient’s drug response.


Clopidogrel doesn’t work for everyone

Pharmacogenetics affects the effectiveness and safety of many medicines depending on the patient’s genetics. Clopidogrel, which is often prescribed to patients after a stroke, is one of these medicines.